ArticleScientific reports2025
Biosynthesis of selenium nanoparticles from Dahlia pinnata tuberous roots with antibacterial, antidiabetic, and erythrocyte membrane protective activities.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Targeting mitochondrial dysfunction and apoptosis in 5-fluorouracil-induced cardiotoxicity using kaempferol-mediated selenium nanoparticles.Scientific reports · 2026Article
- Preventive and Ameliorative Effects of Se- and Zn-Biofortified Chickpeas on MAFLD-Related Metabolic Disturbances.Foods (Basel, Switzerland) · 2026Article
- Green synthesis of selenium nanoparticles using Bacillus sp. strain STG-83: optimization, characterization, and prospects for cancer radiosensitization.Scientific reports · 2026Article
- Green mycosynthesis of a CuO/ZnO heterojunction nanocomposite using Aspergillus terreus and its antibacterial and anti-virulence activity against multidrug-resistant Escherichia coli.Scientific reports · 2026Article
- Selenium Nanoparticles as Versatile Delivery Tools.Pharmaceutics · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Selenium nanoparticles (SeNPs) synthesized using Dahlia pinnata L tuber extract exhibit significant antimicrobial, antidiabetic, and anti-inflammatory properties. This study describes the green synthesis of SeNPs using D. pinnata L. tuber extract, a sustainable approach that leverages plant-based compounds. Green synthesis was confirmed via UV-Vis spectroscopy (280 nm peak), XRD trigonal crystal structure with planes (100), (101), (110), (111), and (201), and TEM (spherical particles, 17.37 nm average size). FTIR revealed functional groups (C-H, C = O, Se-Se), while HPLC identified gallic acid (1070.58 µg/g) and chlorogenic acid (903.87 µg/g). In antimicrobial studies, SeNPs demonstrated strong efficacy against 70 Escherichia coli isolates from laboratory samples of diabetic patients. For 15 multidrug-resistant (MDR, 21.4%) isolates, SeNPs had MICs of 25-50 µg/ml (mean: 35 ± 12 µg/ml) and MBCs of 50-100 µg/ml (mean: 76.6 ± 26 µg/ml). Non-MDR isolates (78.6%) were more sensitive, with MICs of 10-25 µg/ml (mean: 15 ± 4.5 µg/ml) and MBCs of 25-50 µg/ml (mean: 35 ± 12 µg/ml), outperforming selenium precursors and vancomycin. SeNPs also showed antidiabetic potential through α-amylase inhibition (IC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.